Related Experiment Video
Updated: May 13, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?
Vanessa M McDonald1, Isabel Higgins, Lisa G Wood
1School of Nursing and Midwifery, University of Newcastle, Newcastle, New South Wales, Australia.
New approaches for chronic obstructive pulmonary disease (COPD) involve inflammometry and multidimensional assessment. This personalized strategy maximizes treatment efficacy and improves the risk-benefit ratio for patients.
Area of Science:
- Pulmonary Medicine
- Inflammation Research
- Personalized Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) presents a growing global health challenge.
- Current treatment paradigms necessitate innovative strategies to manage disease burden effectively.
Purpose of the Study:
- To introduce a novel, individualized treatment approach for COPD.
- To leverage inflammometry and multidimensional assessment for targeted therapy.
Main Methods:
- Implementing inflammometry to analyze inflammatory pathways.
- Utilizing multidimensional assessment to identify specific therapeutic targets.
- Employing case management for personalized treatment program design and execution.
Main Results:
- The proposed tailored approach aims to maximize therapeutic efficacy.
- This strategy is expected to optimize the cost-effectiveness and risk-benefit ratio of COPD treatments.
- Individual therapies can be cumulatively beneficial, exceeding the sum of their individual effects.
Conclusions:
- A multifaceted inflammometry intervention can target eosinophilic, non-eosinophilic, and systemic inflammation in airway diseases.
- Inflammometry and multidimensional assessment are crucial for identifying COPD treatment targets and optimizing therapy.
- Case management facilitates the design and coordination of individualized COPD management plans, potentially offering significant patient benefits.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...